| Not Yet Recruiting | DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne g NCT06178302 | Imed19 | — |
| Not Yet Recruiting | A Study to Evaluate Safety and Efficacy of PBK_M2502 NCT07114406 | Pharmbio Korea Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF NCT06981520 | Hitit University | — |
| Recruiting | Study of Normal Intestinal Development and Disease in Premature and Term Neonates NCT06681129 | Boston Children's Hospital | — |
| Recruiting | Outcomes of Outpatients in an Gut Microbiota Clinic NCT06845527 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome NCT06271538 | EP Plus Group Sdn Bhd | Phase 4 |
| Recruiting | Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection NCT06112353 | University of California, Irvine | Phase 4 |
| Recruiting | SGM-101 in Colorectal Brain Metastases. NCT04755920 | Leiden University Medical Center | Phase 2 |
| Unknown | A Study to Evaluate Safety and Efficacy of PBK_M2101 NCT05923918 | Pharmbio Korea Co., Ltd. | Phase 3 |
| Unknown | Mental Stress and Bowel Preparation Quality NCT06007313 | RenJi Hospital | — |
| Recruiting | Immune Responses to Gluten NCT05209568 | Boston Children's Hospital | N/A |
| Active Not Recruiting | Gluten-free Diet in PSC and IBD NCT06026449 | Institute for Clinical and Experimental Medicine | N/A |
| Active Not Recruiting | CRC Detection Reliable Assessment With Blood NCT05551052 | New Day Diagnostics | — |
| Unknown | Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/ NCT05249335 | Pharmbio Korea Co., Ltd. | Phase 4 |
| Completed | Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure NCT05234515 | London North West Healthcare NHS Trust | — |
| Completed | Effect of Probiotics on Patients With Congenital Heart Disease Following Cardiopulmonary Bypass NCT06295575 | Nanjing Children's Hospital | N/A |
| Completed | Gut Microbial Changes After Periodontal Treatment NCT04982302 | University of Turin, Italy | — |
| Unknown | The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease. NCT04605627 | Oslo University Hospital | — |
| Unknown | The Detrimental Course of Acute Intestinal Ischemia NCT05194527 | Maastricht University | — |
| Completed | Endoscopist and Endoscope Motions During Colonoscopy NCT04263818 | IHU Strasbourg | N/A |
| Unknown | Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease NCT04123990 | VIFORFRANCE | N/A |
| Unknown | Investigation of Hypophosphataemia Following Intravenous Iron NCT04502784 | Belfast Health and Social Care Trust | — |
| Completed | Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma NCT03559543 | Catalysis SL | Phase 2 |
| Completed | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) NCT03723447 | Cedars-Sinai Medical Center | Phase 4 |
| Unknown | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) NCT03644069 | ImmusanT, Inc. | Phase 2 |
| Completed | Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease NCT03543540 | ImmusanT, Inc. | Phase 1 |
| Suspended | Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease NCT03462979 | Boston Children's Hospital | N/A |
| Completed | Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy NCT03509220 | Pharmbio Korea Co., Ltd. | Phase 3 |
| Completed | Panaceo "MED" for IBS (Irritable Bowel Syndrome) NCT03817645 | Scigenia GmbH | N/A |
| Completed | Environmental Factors and the Gut Microbiome - Endocannabinoid Axis NCT03463304 | Laval University | — |
| Completed | Lanreotide in the Treatment of Small Bowel Motility Disorders NCT03012594 | Northwell Health | Phase 2 |
| Completed | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Unknown | NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer NCT03280407 | Zealand University Hospital | Phase 2 |
| Unknown | Gut Microbiota and Color-rectal Cancer. NCT04662853 | Maimónides Biomedical Research Institute of Córdoba | — |
| Completed | Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection NCT02785783 | Portsmouth Hospitals NHS Trust | N/A |
| Unknown | Indications and Outcomes of Endoscopic Ultrasound in Tanta NCT03267355 | Tanta University | N/A |
| Completed | Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis NCT02569333 | Mount Sinai Hospital, Canada | N/A |
| Completed | Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System NCT04573959 | Capso Vision, Inc. | N/A |
| Completed | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Diseas NCT01787825 | Capso Vision, Inc. | N/A |
| Unknown | Lactated Ringer's Solution in Neonates With Feeding Intolerance NCT01236833 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Completed | A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease NCT00072943 | Facet Biotech | Phase 2 |